Post

New research · Ophthalmology
Indian journal of ophthalmology · 4d
Cohort studyIndian journal of ophthalmology · 2026

Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from adjacent regions.

Aniwat Berpan
Read paper
OphthalmologyCohort study

Regional recurrence occurred in 17.6% of ophthalmic cancer patients after treatment

Locoregional recurrence in carcinoma of the ophthalmic sites: Primary cancer and secondary invasion from adjacent regions.

Aniwat Berpan
Indian journal of ophthalmology · 2026
Background

To evaluate locoregional recurrence in patients treated with local treatment.

Methods

This was an institutional-based retrospective observational cohort study including 36 patients with ophthalmic plus nasal cavity (nasal cavity) and paranasal sinus carcinoma invading ophthalmic structures.

n = 36 patients
Results
17.6%
about 1 in 6 patients had cancer come back nearby after treatment
n = 36 patients
More results

Sebaceous carcinoma was found the most (35.3%), followed by squamous cell carcinoma (squamous cell carcinoma) (29.4%).

23.5% had nodal involvement, precisely within the parotid group.

All patients underwent surgery, including exenteration (n = 6).

Squamous cell carcinoma was found in 73.7%.

“
Conclusion

Patients requiring exenteration probably need postoperative radiotherapy to minimize local recurrence.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving